SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- (Inmagene), a clinical-stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory (I&I) diseases, ...
Some results have been hidden because they may be inaccessible to you